NCT05612048

Brief Summary

The researchers are doing this study to find out more about what may lead to the loss of tooth enamel (the thin outer covering of the tooth) and how often it happens in people with esophagogastric cancer, colorectal cancer, pancreatic cancer, breast cancer, head and neck cancer, or non-small cell lung cancer, or a healthy volunteer.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
174

participants targeted

Target at P75+ for not_applicable

Timeline
18mo left

Started Nov 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Nov 2022Nov 2027

First Submitted

Initial submission to the registry

November 3, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

November 3, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 10, 2022

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

5 years

First QC Date

November 3, 2022

Last Update Submit

March 19, 2026

Conditions

Keywords

Tooth erosionGERDLoss of tooth enamel22-370

Outcome Measures

Primary Outcomes (1)

  • The incidence of dental erosions

    scored with a modified BEWE index.

    1 year

Study Arms (3)

Patients diagnosed with esophagogastric cancer

EXPERIMENTAL

Patients have completed the intervention once completing the survey, undergoing dental imaging and future patients will also provide an optional saliva sample.

Other: SurveyOther: Intra-oral cameraOther: Optional Salvia sample

Patients diagnosed with colorectal, pancreatic, breast, head and neck, or non-small cell lung cancer

EXPERIMENTAL

Patients undergo consenting and dental imaging during their routine visits at MSK.

Other: SurveyOther: Intra-oral camera

Healthy volunteers who have not been diagnosed with cancer

EXPERIMENTAL

Healthy controls will be defined as those without a known or suspected invasive cancer history and excluding those undergoing a procedure for symptomatic reflux.

Other: SurveyOther: Intra-oral camera

Interventions

Intraoral pictures of molars and incisors in 13 key regions

Healthy volunteers who have not been diagnosed with cancerPatients diagnosed with colorectal, pancreatic, breast, head and neck, or non-small cell lung cancerPatients diagnosed with esophagogastric cancer

Cohort 1 only. Participant is responsible for collecting and bringing the salvia sample to clinic.

Patients diagnosed with esophagogastric cancer
SurveyOTHER

This is a 15-item questionnaire. The questionnaire asks subjects to quantify, during a specified duration of time, the number of times they have consumed or completed a task (ex. alcohol intake, cigarette use, and teeth brushing frequency). Additionally, the questionnaire further asks subjects to quantify their GERD symptoms and risk factors prior to diagnosis. All study procedures will be completed in one visit as part of a standard-of-care clinic visit.

Healthy volunteers who have not been diagnosed with cancerPatients diagnosed with colorectal, pancreatic, breast, head and neck, or non-small cell lung cancerPatients diagnosed with esophagogastric cancer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is willing and able to provide written informed consent.
  • Patients with a history of esophagogastric, HNSCC, PDAC, CRC, or NSCLC or healthy controls
  • Patients must be able to fully comprehend and complete the survey and be willing to have pictures taken of their teeth with a camera or intra-oral camera.
  • Patients must be able to understand English language or have access to adequate translation services.
  • Age ≥ 18 years old.

You may not qualify if:

  • Subjects without evaluable molars or with significant molar dental work precluding dentists from assessing enamel status, Note: evaluable is defined as having bilateral assessable mandibular molars, or erosions present in the remaining assessable quadrants.
  • For healthy controls only, patients cannot have a non-skin cancer history nor presenting for a procedure evaluating reflux symptoms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, 10065, United States

Location

Related Links

MeSH Terms

Conditions

Tooth ErosionGastroesophageal Reflux

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic DiseasesTooth WearEsophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Steven Maron, MD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Patients will complete a questionnaire and undergo imaging by the intra-oral camera of their teeth.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2022

First Posted

November 10, 2022

Study Start

November 3, 2022

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

March 23, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org

Locations